Avricore Health (AVCRF) Profit After Tax (2009 - 2026)

Avricore Health (AVCRF) has reported Profit After Tax for 18 consecutive years, with -$148122.3 the latest figure, recorded in Q2 2026.

• In Q2 2026, Profit After Tax rose 55.35% year-over-year to -$148122.3; the TTM figure through Jun 2026 stood at -$1.4 million (down 304.98% YoY), while the FY2025 annual figure was -$1.3 million, down 172.27% from the prior year.
• Profit After Tax grew to -$148122.3 in Q2 2026 per AVCRF's latest filing, from -$676000.8 in the prior quarter.
• Across five years, Profit After Tax topped out at $163943.0 in Q2 2024 and bottomed at -$1.0 million in Q4 2022.
• Historically, Profit After Tax has averaged -$170056.2 across 5 years, with a median of -$144124.5 in 2023.
• Annual changes were most pronounced in 2022 — Profit After Tax slumped 518.65% — and 2024, when it surged 188.29%.
• Avricore Health's Profit After Tax stood at -$1.0 million in 2022, then surged by 104.27% to $43766.6 in 2023, then sank by 400.89% to -$131688.6 in 2024, then slumped by 413.33% to -$676000.8 in 2025, then surged by 78.09% to -$148122.3 in 2026.
• Business Quant data shows AVCRF's Profit After Tax at -$148122.3 in Q2 2026, -$676000.8 in Q4 2025, and -$275431.0 in Q3 2025.